Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + propofol vs midazolam + fentanyl + propofol for pain relief during extracorporeal lithotripsy
IRCT20230701058625N1Phase 4Completed
- Sponsor
- Dezful University of Medical Sciences
- Start
- Oct 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, propofol, midazolam and fentanyl in nephrolithiasis (2 arms), sponsored by Dezful University of Medical Sciences. Started Oct 2023; status: completed.
02
Drugs
dexmedetomidinepropofolmidazolamfentanyl
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT20230701058625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230701058625N1.